Tirzepatide Tirzepatide (Mounjaro, Eli Lilly) is a dual incretin agonist that targets both GLP-1 and GIP receptors
Many people seem to experience symptoms like those you mention - where it has been mentioned in posts my memory is that the individuals concerned report the sleepiness as something that continues as they move into maintenance shots
This includes maintaining a consistent sleep schedule, creating a restful sleeping environment (cool, dark, and quiet), avoiding stimulants like caffeine and nicotine close to bedtime, and limiting exposure to screens before sleep
V opanm ppad bude objednvka stornovna
Gerschman R, Gilbert LD, Nye SW, Dwyer P, Fenn WO
Heart rate increased from baseline across all treatment groups, an effect consistent with prior trials of semaglutide